>Year 2002, Issue 3
Nieto OAE, Ibáñez FJR, Coronado MR, García CG, Charco RCA
Fasciola hepatica. Report on one case
Cir Gen 2002; 24 (3)
PDF: 4. Kb.
Objective: To describe the case of Fasciola hepatica in Mexico.
Design: Report of a case.
Setting: Private practice.
Description of the case: A man, 44 years old, sheep-breeder, in Milpa Alta, an outskirt of Mexico City. He was admitted to the hospital with abdominal pain of 4 weeks of evolution in the hypochondrium, and jaundice. Laboratory tests revealed: Leukocytes of 7150; eosinophils of 16.4%; total bilirubin of 4.18 mg with direct bilirubin of 3.46, and phosphatase of 72 U. The ultrasound revealed a sclerotic and atrophied gallbladder with dilation of the biliary tract. Based on a diagnosis of obstructive jaundice secondary to a probable choledocholithiasis, he was programmed for cholecystectomy with exam of the biliary tract. During surgery, a dilated biliary tract was found together with four adult Fasciola hepatica in its interior. No calculi were found either in the gallbladder or the biliary tract. The patient received albendazol for 7 days after surgery. A year after, he is asymptomatic, without eosinophilia and negative serological test.
Conclusion: Fascioliasis is a common disease in sheep and cows, highly transmissible to humans. In the presence of marked eosinophilia and jaundice, this disease must be suspected and the adequate diagnosis and corresponding treatment must be established.
||Fasciola hepatica, obstructive jaundice, cholecystectomy.
von Lichtenberg F. Enfermedades infecciosas: enfermedades causadas por virus, rickettsias y bacterias. En: Robbins SL, Contran RS, Kumar V. Patología estructural y funcional. 3ª ed. México: Interamericana; 1987; 271-397.
Fournier Villada R. Dos casos de Fasciola hepática encontrados en México. Gac Méd Mex 1946; 76: 208-12.
Sánchez MI. Fasciolosis coledociana en México. Cir Gen 1996; 18: 201-204.
Álvarez BF. Fasciolosis hepática: imágenes de un hallazgo inesperado. Cir Gen 1999; 21(supl 1): 87.
Pérez C, Vives R, Montes M, Ostiz S. Recurrent eosinophilic panniculitis associated with Fasciola hepatica infection. J Am Acad Dermatol 2000; 45(5 pt 2): 900-2.
Arjona R, Riancho JA, Aguado JM, Salesa R, Gonzalez Macias J. Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine (Baltimore) 1995; 74: 13-23.
Rangel-Ruiz LJ, Márquez-Izquierdo R, Bravo Noriega G. Bovine fasciolosis in Tabasco, México. Vet Parasitol 1999; 81: 119-27.
el-Newihi HM, Waked IA, Mihas AA. Biliary complications of Fasciola hepatica: the role of endoscopic retrograde cholangiography in management. J Clin Gastroenterol 1995; 21: 309-11.
Richter J, Freise S, Mull R, Millan JC. Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole. Trop Med Int Health 1999; 4: 774-81.
Kumar A, Gautam A, Chaturvedi S. Obstructive jaundice due to Fasciola hepatica. Indian J Gastroenterol 1995; 14: 79-80.
el-Karaksy H, Hassanein B, Okasha S, Behairy B, Gadallah I. Human fascioliasis in Egyptian children: successful treatment with triclabendazole. J Trop Pediatr 1999; 45: 135-8.
Yilmaz H, Oner AF, Akdeniz H, Arslan S. The effect of triclabendazole (Fasinex) in children with fasciolosis. J Egypt Soc Parasitol 1998; 28: 497-502.
>Year 2002, Issue 3